Page 35 - GPD-4-2
P. 35

Gene & Protein in Disease                                 lncRNAs dysregulation in diabetes and its complications



            89.  Tamgue O, Mezajou CF, Ngongang NN, et al. Non-coding   2015;87:15-24.
               RNAs in the etiology and control of major and neglected      doi: 10.1016/j.addr.2015.05.012
               human tropical diseases. Front Immunol. 2021;12:703936.
                                                               100. Liu J, Yao J, Li X, et al. Pathogenic role of lncRNA-MALAT1
               doi: 10.3389/fimmu.2021.703936
                                                                  in endothelial cell dysfunction in diabetes mellitus.  Cell
            90.  Wang H, Xia Y, Zhang Y. Diagnostic significance of   Death Dis. 2014;5(10):e1506
               serum lncRNA HOTAIR and its predictive value for the      doi: 10.1038/cddis.2014.466
               development of chronic complications in patients with
               type 2 diabetes mellitus. Diabetol Metab Syndr. 2021;13:97.  101. Liu P, Jia SB, Shi JM,  et al. LncRNA-MALAT  promotes
                                                                                                     1
                                                                  neovascularization in diabetic retinopathy through
               doi: 10.1186/s13098-021-00719-3
                                                                  regulating  miR-125b/VE-cadherin  axis.  Biosci
            91.  Chang W, Wang J. Exosomes and their noncoding RNA   Rep. 2019;39(5):BSR20181469.
               cargo are emerging as new modulators for diabetes mellitus.
               Cells. 2019;8(8):853.                              doi: 10.1042/BSR20181469
                                                               102. Shi S, Song L, Yu H,  et al. Knockdown of LncRNA-H19
               doi: 10.3390/cells8080853
                                                                  ameliorates kidney fibrosis in diabetic mice by
            92.  Sanchez-Parra C, Jacovetti C, Dumortier O,  et  al.   suppressing miR-29a-mediated EndMT.  Front Pharmacol.
               Contribution of the long noncoding RNA H19 to  β-cell   2020;11:586895.
               mass expansion in neonatal and adult rodents.  Diabetes.
               2018;67(11):2254-2267.                             doi: 10.3389/fphar.2020.586895
               doi: 10.2337/db18-0201                          103. Zhang W, Cao D, Wang Y, Ren W. LncRNA MEG8 is
                                                                  upregulated in gestational diabetes mellitus (GDM)
            93.  Fawzy MS, Abdelghany AA, Toraih  EA, Mohamed AM.   and  predicted  kidney  injury.  J  Diabetes Complications.
               Circulating long noncoding RNAs H19 and GAS5 are   2021;35(1):107749.
               associated with type  2 diabetes but not with diabetic
               retinopathy: A  preliminary study.  Bosn J Basic Med Sci.      doi: 10.1016/j.jdiacomp.2020.107749
               2020;20(3):365-371.                             104. Zhao C, Hu J, Wang Z, Cao ZY, Wang L. Serum LncRNA
               doi: 10.17305/bjbms.2019.4533                      PANDAR may act as a novel serum biomarker of diabetic
                                                                  nephropathy in patients with type  2 diabetes.  Clin  Lab.
            94.  Zhu X, Wu YB, Zhou J, Kang DM. Upregulation of lncRNA   2020;66(6).
               MEG3 promotes hepatic insulin resistance via increasing
               FoxO1 expression.  Biochem Biophys Res Commun.      doi: 10.7754/Clin.Lab.2019.191032
               2016;469(2):319-325.                            105. Li S, Li Y, Chen B, et al. exoRBase: A database of circRNA,
               doi: 10.1016/j.bbrc.2015.11.048                    lncRNA and mRNA in human blood exosomes.  Nucleic
                                                                  Acids Res. 2018;46(D1):D106-D112.
            95.  Tello-Flores  VA,  Beltrán-Anaya  FO,  Ramírez-Vargas  MA,
               et al. Role of long non-coding RNAs and the molecular      doi: 10.1093/nar/gkx891
               mechanisms involved in insulin resistance.  Int J Mol Sci.   106. Peng L, Yuan X, Jiang B, Tang Z, Li GC. LncRNAs: Key
               2021;22(14):7256.                                  players and novel insights into cervical cancer. Tumor Biol.
               doi: 10.3390/ijms22147256                          2016;37:2779-2788.
            96.  Rashidmayvan M, Sahebi R, Ghayour-Mobarhan M. Long      doi: 10.1007/s13277-015-4663-9
               non-coding RNAs: A  valuable biomarker for metabolic   107. Széll M, Danis J, Bata-Csörgő Z, Kemény L. PRINS, a
               syndrome. Mol Genet Genomics. 2022;297(5):1169-1183.  primate-specific long non-coding RNA, plays a role in the
               doi: 10.1007/s00438-022-01922-1                    keratinocyte stress response and psoriasis pathogenesis.
                                                                  Pflügers Arch. 2016;468:935-943.
            97.  Zhang Y, Wu H, Wang F, Ye M, Zhu H, Bu S. Long non‐
               coding RNA MALAT  expression in patients with gestational      doi: 10.1007/s00424-016-1803-z
                               1
               diabetes mellitus. Int J Gynecol Obstet. 2018;140(2):164-169.  108. Yang Y, Cai Y, Wu G, et al. Plasma long non-coding RNA,
               doi: 10.1002/ijgo.12384                            CoroMarker, a novel biomarker for diagnosis of coronary
                                                                  artery disease. Clin Sci. (Lond). 2015;129(8):675-685.
            98.  Saleh RO, Al-Ouqaili MTS, Ali E, et al. lncRNA-microRNA
               axis in cancer drug resistance: Particular focus on signaling      doi: 10.1042/CS20150121
               pathways. Med Oncol. 2024;41(2):52.
                                                               109. Kaur S, Mirza AH, Brorsson CA,  et al. The genetic
               doi: 10.1007/s12032-023-02263-8                    and regulatory architecture of ERBB3-type  1 diabetes
                                                                  susceptibility locus. Mol Cell Endocrinol. 2016;419:83-91.
            99.  Khorkova O, Hsiao J, Wahlestedt C. Basic biology and
               therapeutic implications of lncRNA.  Adv  Drug  Deliv  Rev.      doi: 10.1016/j.mce.2015.10.002


            Volume 4 Issue 2 (2025)                         15                              doi: 10.36922/gpd.4000
   30   31   32   33   34   35   36   37   38   39   40